维普期刊资源整合服务平台（V6.5）

68篇 您的检索式：作者名="DIEL I"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review 显示文摘	Diel I J Weide R Koppler H	2009	Support Care Cancer2009，17，6：	1
2	Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: is there a diverse relationship of amino- and non-aminobisphosphonates? 显示文摘	Diel IJ Fogelman I Al-Nawas B	2007	Crit Rev Oncol Hematol2007，64，3：	1
3	Concentrationg of TGF-beta in human bone tiusse:relationship to age,menopause,bone turnover,and bone volume显示文摘	Pfeilschifter J Diel I Scheppach B	1998	J Bone Miner1998，13，4：	1
4	Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice显示文摘	BECKHOVE P SCHUTZ F DIEL I J		0，，04：	1
5	Reduction in new metastases in breast cancer with adjuvant clodronate treatment 显示文摘	Diel I J Solomayer E F Costa S D	1998	N Engl J Med1998，339，6：	1
6	Adjuvant treatment of breast cancer patients with the bisphosphonate clodronate reduces incidence and number of bone and nonbone metastases 显示文摘	Diel I Solomayer EF Goemer R	1997	Proc Am Soc Clin Oncol1997，16，1：	1
7	Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up 显示文摘	Diel I J Jaschke A Solomayer E F	2008	Ann Oncol2008，19，12：	1
8	Ibandronate:efficacy in the treatment of metastatic bone disease显示文摘	DIEL I J	2005	Fut Oncol2005，1，5：	1
9	Treatment of metastatic bone disease in breast cancer:bisphosphonates显示文摘	DIEL I J SOLOMAYER E F BASTERT G		0，，01：	1
10	Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice显示文摘	Beckhove P Schutz F Diel I J	2003	Int J Cancer2003，105，4：	1
11	Metastatic breast cancer:clinical course, prognosis and therapy relat- ed to the first site of metastasis 显示文摘	Solomayer E F Diel I J Meyberg G C	2000	Breast Cancer Res Treat2000，59，3：	1
12	Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients 显示文摘	Solomayer EF Diel I J Salanti G	2001	Clin Cancer Res2001，7，12：	1
13	Serum parathyroid hormone,but not menopausal status,is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples显示文摘	Seck T Diel I Bismar H		0，，02：	1
14	Renal safety of ibandronate in patients with bone metastases from breast cancer: phase Ⅲ trial results显示文摘	BELL R DIEL I J BODY J J	2004	EJC2004，2，12：	1
15	Tidal and Vertical Variations of Phytoplankton and Its Environment in Frobisher Bay显示文摘	Hsiao S I C Diel	1992	Arctic1992，45，4：	1
16	Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis显示文摘	Diel I J Solomayer E F Seibel M J	1999	Clin Cancer Res1999，5，12：	1
17	Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase Ⅲ trial results 显示文摘	BODY J J DIEL I J TRIPATHY D	2006	Eur J Cancer Care2006，15，3：	1
18	Micrometastatic cancer cells in bone marrow at primary surgery:Prognostic value in comparison with nodal status显示文摘	Diel I J Kaufmann M Costa SD	1996	J N atl Cancer Inst1996，88，22：	1
19	Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer显示文摘	Diel I J Cote RJ	2000	Cancer Treat Rev2000，26，：	1
20	Litter processing and population food intake oft he mangrove crab Ucides cordatus in a high intertidal forest in northern Brazil显示文摘	NORDHAUS I WOLFF M DIELE K	2006	Estuarine Coastal and Shelf Science2006，67，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示